A Study of the RNA Tumor Vaccine Targeting MICA/B in Patients With Advanced Solid Tumors
Clinical trial NCT06610227 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06610227
- Sponsor
- NING LI
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-08
- Primary completion
- 2025-09-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.